Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nishan H Fernando

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|June 13, 2003
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancerNishan H Fernando, Herbert I Hurwitz
The Oncologist|June 5, 2004
Targeted therapy of colorectal cancer: clinical experience with bevacizumabNishan H Fernando, Herbert I Hurwitz
The Annals of Pharmacotherapy|March 24, 2005
Successful desensitization to oxaliplatinLydia Mis, Nishan H Fernando, Hurbert I Hurwitz, et al.
Clinical Colorectal Cancer|August 23, 2011
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Johanna C Bendell, et al.
Anticancer Research|January 2, 2010
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experienceBrian G Czito, Herbert I Hurwitz, Robert W Clough, et al.
Anticancer Research|June 10, 2010
A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
Anticancer Research|January 29, 2011
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Andrew B Nixon, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinomaBrian G Czito, Chris R Kelsey, Herbert I Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial resultsBrian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|June 13, 2003
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancerNishan H Fernando, Herbert I Hurwitz
The Oncologist|June 5, 2004
Targeted therapy of colorectal cancer: clinical experience with bevacizumabNishan H Fernando, Herbert I Hurwitz
The Annals of Pharmacotherapy|March 24, 2005
Successful desensitization to oxaliplatinLydia Mis, Nishan H Fernando, Hurbert I Hurwitz, et al.
Clinical Colorectal Cancer|August 23, 2011
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Johanna C Bendell, et al.
Anticancer Research|January 2, 2010
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experienceBrian G Czito, Herbert I Hurwitz, Robert W Clough, et al.
Anticancer Research|June 10, 2010
A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
Anticancer Research|January 29, 2011
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Andrew B Nixon, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinomaBrian G Czito, Chris R Kelsey, Herbert I Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial resultsBrian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Pageof 2